Pharmacovigilance Automation Market Size to Reach USD 5.25 Billion by 2035 | SNS Insider

The global Pharmacovigilance Automation Market is expected to grow at a CAGR of 6.50% from 2025 to 2035, driven by increasing AI adoption, stringent drug safety regulations, and rising adverse event reporting volumes. North America leads with 38.60% market share, while Europe shows the fastest growth at 18.9% CAGR. Software solutions dominate with 72.40% market share, and pharmaceutical companies account for 58.60% of end-user demand.